Dual-function protein for lipid and blood glucose regulation
AssigneeAmpsource Biopharma Shanghai Inc.
InventorsZhao DONG, Chi ZHOU, Xiong FENG, Jiyu ZHANG, Shixiang JIA, Qiang LI
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmpsource Biopharma Shanghai Inc.
InventorsZhao DONG, Chi ZHOU, Xiong FENG, Jiyu ZHANG, Shixiang JIA, Qiang LI
Estimating the term…
The present disclosure relates to a dual-function protein for regulating blood glucose and lipid metabolism, wherein said dual-function protein comprises a human GLP-1 analog and human FGF21. In the present disclosure, provided is a method for preparing said dual function protein, and also provided is the use of said dual-function protein in the preparation of a biological substance for treating type 2 diabetes, obesity, dyslipidemia, fatty liver disease and/or metabolic syndrome. The dual-function protein provided in the present disclosure can synergistically regulate blood glucose and lipid levels in vivo, and satisfy multiple requirements for patients with type 2 diabetes such as lowering blood glucose, relieving hepatic steatosis, reducing body weight and improving metabolic disorders of circulating lipids.
-26. (canceled)
A method of treatment of one or more diseases, comprising administering to a person suffering from at least one of said diseases an effective amount of one or more dual-function proteins;
(canceled)
A method of treatment of one or more diseases, comprising administering to a person suffering from at least one of said diseases an effective amount of a pharmaceutical composition comprising a dual-function protein comprising the amino acid sequence of SEQ ID NO:
(canceled)
Dependencies are inferred from the claim text.